MIRA INFORM REPORT

 

 

Report Date :

11.05.2013

 

IDENTIFICATION DETAILS

 

Name :

BIOGENTEK BG (INDIA) PRIVATE LIMITED

 

 

Registered Office :

106, Shahpuri Tirath Singh Tower, C-58, Community Centre, C Block, Janak Puri, New Delhi – 110058

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

13.03.1998

 

 

Com. Reg. No.:

55-093006

 

 

Capital Investment / Paid-up Capital :

Rs.0.100 Million

 

 

CIN No.:

[Company Identification No.]

U74130DL1998PTC093006

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of
Sensors Transducers and Weighing Scales Measuring Tapes.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (43)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 15000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track record. Trade relations are reported as fair. Business is active. Payments are reported to be usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

LOCATIONS

 

Registered Office/ Head Office :

106, Shahpuri Tirath Singh Tower, C-58, Community Centre, C Block, Janak Puri, New Delhi – 110058, India 

Tel. No.:

91-11-25573125/ 25513104

Fax No.:

91-11-25513106

E-Mail :

office@biogentek.com

ravindra@biogentek.com

Website :

http://www.biogentek.com

 

 

Branch Office :

Located at:

 

  • New Delhi
  • Lucknow
  • Varanasi
  • Guwahati
  • Kolkata
  • Bhubaneswar
  • Hyderabad
  • Trivandrum
  • Bangalore
  • Mumbai
  • Pune
  • Ahmedabad

 

 

DIRECTORS

 

As on: 28.09.2012

 

Name :

Mr. Neeraj Pandey

Designation :

Director

Address :

C-8/8005, Vasant Kunj, New Delhi – 110070, India

Date of Appointment :

13.03.1998

DIN No.:

01135827

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U74130DL1998PTC093006

BIOGENTEK BG (INDIA) PRIVATE LIMITED

Director

13/03/1998

13/03/1998

-

Active

NO

2

U29299DL2005PTC134585

INSTRUMEK INDIA PRIVATE LIMITED

Director

31/03/2005

31/03/2005

-

Dormant

NO

 

 

Name :

Mr. Sanjay Gulati

Designation :

Director

Address :

GH9/204, Pachim Vihar, New Delhi – 110063, India

Date of Appointment :

13.03.1998

DIN No.:

01135794

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on: 28.09.2012

 

Names of Shareholders

 

 

No. of Shares

Neeraj Pandey

 

5000

Sanjay Gulati

 

5000

 

 

 

Total

 

10000

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on: 28.09.2012

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of
Sensors Transducers and Weighing Scales Measuring Tapes.

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

  • Canara Bank, Janakpuri, New Delhi – 110058, India
  • Corporation Bank, Pankha Road, Janakpuri, New Delhi – 110058, India

 

 

Facilities :

 

(Rs. in Millions)

Secured Loan

As on

31.03.2012

As on

31.03.2011

Car Loan from Bank

0.196

0.468

Overdraft from Bank

0.027

0.101

 

 

 

Total

0.223

0.569

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Rajendra Singh and Company

Chartered Accountants

Address :

S-3, Pankaj Central Market, IP Extension, Patparganj, New Delhi – 110091, India

Tel. No.:

91-11-22233057

E-mail:

singh_rajendra@vsnl.net 

PAN.:

AAQPS9850G

 

 

CAPITAL STRUCTURE

 

As on 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

50000

Equity Shares

Rs.10/- each

Rs.0.500 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000

Equity Shares

Rs.10/- each

Rs.0.100 Million

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2012

31.03.2011

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

0.100

0.100

0.100

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

3.863

2.981

2.222

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

3.963

3.081

2.322

LOAN FUNDS

 

 

 

1] Secured Loans

0.223

0.569

0.824

2] Unsecured Loans

1.596

0.500

0.000

TOTAL BORROWING

1.819

1.069

0.824

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

5.782

4.150

3.146

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

3.662

2.999

1.905

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.185

0.240

0.271

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

0.065
0.000
0.000

 

Sundry Debtors

1.520
0.531
1.360

 

Cash & Bank Balances

2.706
3.482
2.999

 

Other Current Assets

0.000
0.000
0.000

 

Loans & Advances

9.894
3.674
3.907

Total Current Assets

14.185
7.687
8.266

Less : CURRENT LIABILITIES & PROVISIONS

 
 
 

 

Sundry Creditors

4.626
1.670
1.923

 

Other Current Liabilities

5.591
3.430
4.073

 

Provisions

2.033
1.676
1.300

Total Current Liabilities

12.250
6.776
7.296

Net Current Assets

1.935
0.911
0.970

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

5.782

4.150

3.146

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Income

 

 

Other Income

 

 

 

 

 

TOTAL                                    

NA

17.351

15.342

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                    

NA

16.185

13.969

 

 

 

 

 

 

PROFIT BEFORE TAX

1.294

1.166

1.373

 

 

 

 

 

Less

TAX                                                                 

0.412

0.408

0.423

 

 

 

 

 

 

PROFIT AFTER TAX

0.882

0.759

0.950

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

2.981

2.222

1.272

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

3.863

2.981

2.222

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

                      Export Earnings

22.356

18.321

15.554

 

TOTAL EARNINGS

22.356

18.321

15.554

 

 

 

 

 

 

Earnings Per Share (Rs.)

88.20

75.88

95.02

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

NA
4.37
6.19

 

 

 
 
 

Return on Total Assets

(PBT/Total Assets}

(%)

7.25
10.91
13.50

 

 

 
 
 

Return on Investment (ROI)

(PBT/Networth)

 

0.33
0.38
0.59

 

 

 
 
 

Debt Equity Ratio

(Total Debt/Networth)

 

0.46
0.35
0.35

 

 

 
 
 

Current Ratio

(Current Asset/Current Liability)

 

1.16
1.13
1.13

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last two years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

Note:

 

The registered office of the company has been shifted from 306, Shahpuri Tirath Singh Tower, C-58, Community Centre, C Block, Janak Puri, New Delhi – 110058, India to the present address w.e.f. 01.05.2011.

 

 

UNSECURED LOAN

(Rs. In Millions)

Particular

As on

31.03.2012

As on

31.03.2011

Loan from Directors

1.700

0.500

From Chit Funs Loan (B.L.B. Chits Private Limited)

(0.104)

0.000

 

 

 

Total

1.596

0.500

 

 

BANKERS CHARGES REPORT AS PER REGISTRY

 

Corporate identity number of the company

U74130DL1998PTC093006

Name of the company

BIOGENTEK BG (INDIA) PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

106, Shahpuri Tirath Singh Tower, C-58, Community Centre, C Block, Janak Puri, New Delhi – 110 058, India

E-Mail: ravindra@biogentek.com

This form is for

Modification of charge

Charge identification (ID) number of the charge to be modified

10263601

Type of charge

Immovable property

Particular of charge holder

Corporation Bank, Pankha Road, Janakpuri, New Delhi – 110058, India

E-mail: cb522@corpbank.co.in

Nature of instrument creating charge

Bank Guarantee Limit and over Draft Limit of (Rs. 8.000 Millions Bank Guarantee and Over Draft Limit Rs.0.800 Million)

Hypothecation Deed

Date of instrument Creating the charge

12.03.2013

Amount secured by the charge

Rs.8.800 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest

11.35% p.a. (Bases Rate 10.25+1.10) As per H.O.

 

Terms of Repayment

As per Agreement

 

Margin

As per Agreement

 

Extent and Operation of the charge

As per Agreement

Short particulars of the property or asset(s) charged (including complete address and location of the property)

Office Premises No. 8, 2nd Floor, Kris Korner Commercial Plaza, Oppisit Swastick Residency, Ghoudbudnder, Thane (Maharashtra) (West).

 

Vacant Plot No. 97,Block, Khasara No. 1151, Minj, Aurangabad Jagir,Royal City behind Omaxe City, Bijnaur Road, Lucknow (Uttar Pradesh)

 

Cash Margin 25% of Rs.8.000 Millions.

Particulars of the present modification

Prior to modification Bank guarantee limit is Rs. 4.000 Millions and Bank over draft limit is Rs. 0.100 Million  now it is enhance for Bank guarantee limit 8.000 Millions  and Bank over draft limit Rs.0.800 (Rupees Eight Million).

 

 

FIXED ASSETS:

 

  • Furniture and Fixture
  • Car
  • Computer
  • Office Equipments
  • Cycle
  • Scooter
  • Air Conditioner
  • Building
  • TV
  • Temporary Structures

 

 

WEBSITE DETAILS:

 

PROFILE:

 

Biogentek, one of India 's premier biotechnology enterprise, was founded as a partnership company in 1993 with the objective to be one of the most trusted partners towards Laboratory Research and biopharma production in collaboration with some of the best manufacturers of the below said product line in the world. In 1998, it was incorporated as a Private limited company "Subject".


Biogentek, as on date, is a team of over 50 Professionals, providing sales and services support all over the country with Headquarters in New Delhi and branches in Lucknow, Mumbai, Pune, Ahmedabad, Hyderabad, Bengaluru, Thiruvananthapuram, Bhubaneshwar and Guwahati. It is their constant endeavor to be one of the best service providers to their valued users all over the country and to grow with their respective partnering companies / Principal companies.


Ever since its inception, they at Biogentek, have truly been working with the philosophy of Total Customer Satisfaction”, may it be by virtue of instrumentation supplied or the related after sales services rendered to their valued customers. For us, every user of ours has been a milestone achieved in their quest to excel in terms of support.

A dedicated team of their service personnel always in pursuit of excelling through their relentless efforts are available at the services of their valued customers at all times, especially in situations, when the researcher or the production house is in need of some emergency assistance.


Their association with their esteemed users over the years and their laudable and worthy suggestions henceforth, have provided us with the necessary momentum to keep ourselves continuously upgraded and be associated with remarkably high quality product lines from all over the Europe and the United States.


Some of their important associate / principal companies as represented by us are : Kuhner AG, Switzerland for shakers and incubator shakers, LEEC Limited., UK for the CO2 incubators, Nexcelom Biosciences USA for automatic Cell counters, Applikon Biotechnology Holland for Bioreactors - from Micro Scale to production scale, Lab scale and Scale up tools, Labconco Corporation USA for freeze dryers, speedvac concentrators, biological safety cabinets, Rotary evaporators, water purification systems, Glove boxes, hepa filtered controlled atmosphere PCR enclosures etc.


While the company with its sustained endeavors would continue to enhance its impetus in the biotechnology business, due emphasis to keep pace with the dynamically changing requirements of the research and production community, especially the Biopharmaceutical World (where India is readying itself to face the challenges of the Patent regime) in the long term, emerges as the key anchor of their future growth.

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.54

UK Pound

1

Rs.84.19

Euro

1

Rs.71.11

 

INFORMATION DETAILS

 

Report Prepared by :

VRN

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

4

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

43

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.